HDAC6-IN-22 (compound 30) is a inhibitor of HDAC6, with the IC50 of 4.63 nM. HDAC6-IN-22 has antiproliferative effects in vitro and in vivo towards multiple myeloma. HDAC6-IN-22 induces cell cycle arrest in the G2 phase and promotes apoptosis through the
Molecular Weight:
400.47
Formula:
C24H24N4O2
Target:
Apoptosis,HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted